The future of lung cancer therapy: Striding beyond conventional EGFR and ALK treatments.
Iyer S, Prajapati R, Ramesh A, Basavalingegowda M, Todur S, Kavishvar S, Vijaykumar R, Naik R, Kulkarni P, Bhatt AD, Maniar V, Maka V, Thungappa SC, Singhal M, Ranade A, Shafi G.
Iyer S, et al. Among authors: shafi g.
Mol Clin Oncol. 2019 Apr;10(4):469-475. doi: 10.3892/mco.2019.1811. Epub 2019 Feb 20.
Mol Clin Oncol. 2019.
PMID: 30931120
Free PMC article.